Crabtree, Juliet2016-09-192016-09-192016-07https://hdl.handle.net/11299/182251University of Minnesota Ph.D. dissertation. July 2016. Major: Microbiology, Immunology and Cancer Biology. Advisor: Erik Peterson. 1 computer file (PDF); viii, 85 pages.High-affinity antibody production, T cell activation, and Interferon upregulation all contribute to protective immunity that occurs in humans following influenza immunization. Hematopoietic cell-specific PTPN22 encodes Lymphoid Phosphatase (Lyp), which regulates lymphocyte antigen receptor and Pattern Recognition Receptor (PRR) signaling. A PTPN22 variant R620W (LypW) predisposes to autoimmune and infectious disease, and confers altered signaling through antigen receptors and PRRs. We tested the hypothesis that LypW-bearing humans would have diminished immune response to trivalent influenza vaccine (TIV). LypW carriers exhibited decreased induction of influenza-specific CD4 T cells expressing effector cytokines, and failed to increase antibody affinity following TIV. No differences between LypW carriers and non-carriers were observed in virus-specific CD8 T cell responses, early interferon transcriptional responses, or myeloid APC costimulatory molecule upregulation. LypW association with defects in TIV-induced CD4 T cell expansion and antibody affinity maturation suggests that LypW may predispose to diminished capacity to generate protective immunity against influenza.enPTPN22VaccineThe Function of PTPN22 and the Autoimmune Risk Variant LypW in Immune Responses to VaccinationThesis or Dissertation